The CFI gene gives your body instructions to make factor I, a protein that helps keep one part of your immune system from staying switched on too long. If this gene does not work properly, inflammation may become less controlled, which can raise the chance of infections and contribute to kidney or eye conditions. This gene plays an important role in protecting tissues while still allowing your immune system to fight germs. Some people learn about the CFI gene through testing for unexplained kidney disease or age-related macular degeneration risk.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
CFIGene function
What if the gene works
The CFI gene helps make factor I, a blood protein that keeps part of your immune system from becoming overactive. This helps your body clear germs while limiting inflammation and protecting healthy tissues.
Risk
What if the gene does not work
Variants in the CFI gene can leave too little factor I working. More severe variants may lead to infections, while milder or partial loss can raise the chance of kidney disease caused by an overactive immune system and macular degeneration.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the CFI gene does not currently point to a treatment or drug choice specific to CFI in clinical guidelines. The CFI gene is being studied as a biomarker and as a target for factor I replacement or gene therapy in some complement related eye and kidney conditions.
Conditions associated with CFI
Gene function
What if the gene works
Your immune system needs careful control so it can tag germs and damaged material without bothering healthy tissues. The CFI gene helps provide that control by making factor I, a blood protein that fine tunes the complement system, part of your body’s rapid immune defense. In simple terms, normal CFI gene function helps keep this response targeted and balanced.
The CFI gene makes a protein that acts like a brake on the complement system, a fast part of immune defense. This helps keep immune activity measured instead of spreading too widely.
Factor I cuts C3b and C4b, two complement tags used during immune responses. It works with helper proteins to lower those signals after they have marked a target.
By limiting complement activity on your own cells and tissues, the CFI gene helps the immune system stay focused. This is a key part of how the CFI gene works in normal immune regulation.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help explain normal differences among people, such as appearance, metabolism, or how the body reacts to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can affect how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFI gene often lower the amount of factor I protein made, prevent it from folding or being released properly, or reduce how well it cuts complement proteins such as C3b and C4b. This explains how CFI gene variants affect complement factor I activity at a cellular level. Milder variants may leave partial activity, while more disruptive variants can leave very little or none. Greater loss of function is often linked to earlier or more pronounced complement mediated disease.
How variants are linked to conditions
Pathogenic variants in the CFI gene can cause complement factor I deficiency, which may appear with repeated infections or immune related problems. They are also a recognized cause of some cases of atypical hemolytic uremic syndrome, a condition affecting the blood and kidneys. CFI gene variants and age-related macular degeneration are also linked in research, especially certain rare variants that raise risk rather than make vision loss certain.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply add to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For some CFI changes, risk can be higher when other inherited changes in the immune system are also present, and the exact effect depends on the condition linked to that variant. In people with CFI-related risk for age-related macular degeneration, smoking is a well-known factor that can further raise risk.
Inheritance of CFI variants
How CFI gene variants are inherited depends on the condition they are linked to. For complete factor I deficiency, variants in the CFI gene usually follow an autosomal recessive pattern, so a child inherits one altered copy from each parent. For some complement related kidney conditions, including atypical hemolytic uremic syndrome, a single altered copy in the CFI gene can be involved, which is often described as autosomal dominant with incomplete penetrance, meaning not everyone who inherits the variant becomes ill. Because of this, CFI gene inheritance is not described by one single pattern for every CFI related condition.
What does my CFI result mean for my family?
For family members, what a CFI result means depends on which CFI-related condition or result is involved. Some CFI changes are linked to a dominant pattern, so close relatives may also carry the same change and may want to discuss testing; some cases can also happen for the first time in one person. Other CFI changes cause a recessive condition, which means relatives may be healthy carriers without knowing it.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CFI gene, doctors use CFI genetic testing, which reads your DNA from a blood or saliva sample. The lab compares your CFI gene with the usual sequence and reports whether any variants were found, along with their likely clinical meaning.
When should I consider getting a genetic test?
Consider CFI genetic testing if you or a close relative has had a rare form of kidney failure with blood problems, called atypical hemolytic uremic syndrome, certain inherited kidney diseases, or repeated serious infections linked to low complement factor I. It may also be useful in some families with macular degeneration.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also shape how the body works. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work well for one person but less well or cause more side effects in another. Some people break down or move a drug through the body differently, which can change how much of the medicine reaches its target. These differences are common and help explain why medication response is not exactly the same from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. It focuses on connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. Understanding this can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CFI gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general concerns about symptoms, treatment, or side effects are best discussed with your doctor.
History
Research on the complement system in the mid 1900s gradually led scientists to identify factor I as one of the proteins that helps keep this immune pathway under control. Building on this early work, the CFI gene was mapped and characterized as genetics methods improved in the late 20th century. Researchers then connected inherited CFI variants with rare complement related conditions, showing that some families with repeated infections or uncontrolled inflammation shared changes in this gene. Later studies linked certain CFI variants to age related macular degeneration, which widened medical interest beyond rare disease. Over time, descriptions became more precise as DNA testing helped doctors match specific gene changes with different patterns of illness.